Binding of neuroleptic drugs ( trifluoperazine and rimcazole) to vanilloid receptors in porcine dorsal horn

European Journal of Pharmacology

Volumn 298, Issue 3, 1996, Pages 321-327

  Szallasi, Arpad ^a   Nilsson, Siv ^a   Blumberg, Peter M ^b   Hökfelt, Tomas ^a   Lundberg, Jan M ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Capsazepine; Cooperative binding; Neuroleptic; Vanilloid receptor; 3H Resiniferatoxin

Indexed keywords

CAPSAICIN; CAPSAZEPINE; NEUROLEPTIC AGENT; RADIOLIGAND; RESINIFERATOXIN; RIMCAZOLE; TRIFLUOPERAZINE; UNCLASSIFIED DRUG; VANILLOID RECEPTOR; VANILLOID RECEPTOR AGONIST; VANILLOID RECEPTOR ANTAGONIST;

ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING COMPETITION; CONTROLLED STUDY; DRUG MECHANISM; DRUG RECEPTOR BINDING; FEMALE; HUMAN; HUMAN TISSUE; MEMBRANE BINDING; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR OCCUPANCY; SPECIES DIFFERENCE; SPINAL CORD DORSAL HORN; SWINE;

ADULT; ANIMALS; ANTIPSYCHOTIC AGENTS; AUTORADIOGRAPHY; BINDING SITES; BINDING, COMPETITIVE; CAPSAICIN; CARBAZOLES; DITERPENES; FEMALE; HUMANS; MEMBRANES; NEUROTOXINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DRUG; SPINAL CORD; TRIFLUOPERAZINE;

EID: 0029871198     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(95)00805-5     Document Type: Article

References (37)

1. 3H]Resiniferatoxin binding to pig dorsal horn membranes displays positive cooperativity, Life Sci. 55, 337.
2. 45Ca uptake by adult rat dorsal root ganglion neurones, J. Pharmacol. Exp. Ther. 274, 1090.
3. Alving, K., R. Matran and J.M. Lundberg, 1991, Capsaicin-induced local effector responses, sympatho-adrenal reflexes and sensory neuropeptide depletion in the pig, Naunyn-Schmied. Arch. Pharmacol. 343, 37.
4. Arner, S. and B.A. Myerson, 1988, Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain, Pain 33, 11.
5. Bevan, S., I.F. James, H.P. Rang, J. Winter and J.N. Wood, 1987, The mechanism of action of capsaicin - a sensory neurotoxin, in: Neurotoxins and Their Pharmacological Applications, ed. P. Jenner (Raven Press, New York) p. 261.
6. Bevan, S., S. Hothi, G. Hughes, I.F. James, H.P. Rang, K. Shah, C.S.J. Walpole and J.C. Yeats, 1992, Capsazepine: a competitive antagonist of the sensory neurone excitant capsaicin, Br. J. Pharmacol. 107, 554.
7. Blumberg, P.M., A. Szallasi and G. Acs, 1993, Resiniferatoxin - an ultrapotent capsaicin analogue, in: Capsaicin in the Study of Pain, ed. J.N. Wood (Academic Press, New York) p. 45.
8. Connolly, J., J. Boulter and S.F. Heinemann, 1992, α4-2β2 and other nicotinic acetylcholine receptor subtypes as targets of psychoactive and addictive drugs. Br. J. Pharmacol. 105, 657.
9. Davis, M.E., T. Akera, T.M. Brody and L. Watson, 1977, Opiate receptor: cooperativity of binding observed in brain slices, Proc. Natl. Acad. Sci. USA 74, 5764.
10. Elling, C.E., S.M. Nielsen and T.W. Schwartz, 1995, Conversion of antagonist-binding site to metal-ion site in the tachykinin NK-1 receptor, Nature 374, 74.
11. Endrenyi, L., C. Fajszi and F.H. Kwong, 1975, Evaluation of Hill slopes and Hill coefficients when the saturation binding or velocity is not known, Eur. J. Biochem. 51, 317.
12. Franco-Cereceda, A. and J.M. Lundberg, 1989, Post-occlusive reactive hyperaemia in the heart, skeletal muscle and skin of control and capsaicin-pretreated pigs, Acta Physiol. Scand. 137, 2711.
13. Gether, U., X. Emonds-Alt, J.-C. Breliere, T. Fujii, D. Hagiwara, L. Pradier, C. Garret, T.E. Johansen and T.W. Schwartz, 1994, Evidence for a common molecular mode of action for chemically distinct nonpeptide antagonists at the neurokinin-1 (substance P) receptor, Mol. Pharmacol. 45, 500.
14. Hollister, L.E., 1992, Antipsychotic agents and lithium. Antidepressant agents, in: Basic and Clinical Pharmacology, ed. B.G. Katzung (Appleton & Lange, Norwalk) p. 395.
15. Holzer, P., 1991, Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons, Pharmacol. Rev. 43, 144.
16. Lynn, B., 1990, Capsaicin: actions on nociceptive C-fibers and therapeutic potential, Pain 41, 61.
17. Maderspach, K. and C. Fajszi, 1982, β-Adrenergic receptors of brain cells. Membrane integrity implies apparent positive cooperativity and higher affinity, Biochim. Biophys. Acta 692, 469.
18. Matran, R., K. Alving and J.M. Lundberg, 1990, Cigarette smoke, nicotine and capsaicin aerosol-induced vasodilatation in pig respiratory mucosa, Br. J. Pharmacol. 100, 535.
19. Monod, J., J. Wyman and J.-P. Changeux, 1965, On the nature of allosteric transitions: a plausible model, J. Mol. Biol. 12, 88.
20. Portenoy, R.K., 1992, Cancer pain: pathophysiology and syndromes, Lancet 339, 1026.
21. Portenoy, R.K., K.M. Foley and C.E. Inturrisi, 1990, The nature of opioid responsiveness and its implications for neuropathic pain: a new hypothesis derived from studies of opioid infusions, Pain 43, 273.
22. Rosenkilde, M.M., M. Cahir, U. Gether, S.A. Hjorth and T.W. Schwartz, 1994, Mutations along transmembrane segment II of the NK-1 receptor affect substance P competition with non-peptide antagonists but not substance P binding, J. Biol. Chem. 269, 28160.
23. Roufogalis, B.D., A.M. Minocherhomjee and A. Al-Jobore, 1983, Pharmacological antagonism of calmodulin, Can. J. Biochem. Cell Biol. 61, 927.
24. Schwartz, J.A. and D.F. Skafar, 1993, Ligand-mediated modulation of estrogen receptor conformation by estradiol analogs, Biochemistry 32, 10109.
25. Stjärne, P., J. Rinder and P. Delay-Goyet, 1994, Effects of NK1 receptor antagonists on vasodilatation induced by chemical and electrical activation of sensory C-fibre afferents in different organs, Acta Physiol. Scand. 152, 153.
26. Szallasi, A., 1994, The vanilloid (capsaicin) receptor: receptor types and species differences, Gen. Pharmacol. 25, 223.
27. Szallasi, A. and P.M. Blumberg, 1989, Resiniferatoxin, a phorbol-related diterpene, acts as an ultrapotent analog of capsaicin, the irritant constituent in red pepper, Neuroscience 30, 515.
28. Szallasi, A. and P.M. Blumberg, 1990a, Specific binding of resiniferatoxin, an ultrapotent capsaicin analog, by dorsal root ganglion membranes, Brain Res. 524, 106.
29. Szallasi, A. and P.M. Blumberg, 1990b, Resiniferatoxin and analogs provide novel insights into the pharmacology of the vanilloid (capsaicin) receptor, Life Sci. 47, 1399.
30. Szallasi, A. and P.M. Blumberg, 1991, Characterization of vanilloid receptors in the dorsal horn of pig spinal cord, Brain Res. 547, 335.
31. Szallasi, A. and P.M. Blumberg, 1993, Mechanisms and therapeutic potential of vanilloids (capsaicin-like molecules), Adv. Pharmacol. 24, 123.
32. 1,-acid glycoprotein (orosomucoid) as a major vanilloid-binding protein in serum, J. Pharmacol. Exp. Ther. 262, 883.
33. Szallasi, A., N.E. Lewin and P.M. Blumberg, 1993a, Vanilloid (capsaicin) receptors in the rat: positive cooperativity of resiniferatoxin binding and its modulation by reduction and oxidation, J. Pharmacol. Exp. Ther. 266, 678.
34. 3H]resiniferatoxin binding to central (spinal cord and dorsal root ganglia) and peripheral (urinary bladder and airways) vanilloid (capsaicin) receptors in the rat, J. Pharmacol Exp. Ther. 267, 728.
35. 3H]resiniferatoxin autoradiography of capsaicin-sensitive neurons in the rat, pig and man, Eur. J. Pharmacol. 264, 217.
36. Szolcsanyi, J., 1991, Perspectives of capsaicin-type agents in pain therapy and research, in: Contemporary Issues in Chronic Pain Management, ed. W.C.V. Parris (Kluwer Academic, Boston) p. 97.
37. Wood, J.N., J. Winter, I.F. James, H.P. Rang, J. Yeats and S. Bevan, 1988, Capsaicin-induced ion fluxes in dorsal root ganglion cells in culture, J. Neurosci. 8, 3208.